0.4939
1.57%
-0.0141
Precedente Chiudi:
$0.508
Aprire:
$0.5078
Volume 24 ore:
26,321
Relative Volume:
0.04
Capitalizzazione di mercato:
$48.01M
Reddito:
-
Utile/perdita netta:
$-102.09M
Rapporto P/E:
-0.8899
EPS:
-0.555
Flusso di cassa netto:
$-108.72M
1 W Prestazione:
-10.71%
1M Prestazione:
-28.67%
6M Prestazione:
-59.08%
1 anno Prestazione:
-69.14%
Dbv Technologies Adr Stock (DBVT) Company Profile
Nome
Dbv Technologies Adr
Settore
Industria
Telefono
33(0)155427878
Indirizzo
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Confronta DBVT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
DBVT | 0.494 | 48.01M | 0 | -102.09M | -108.72M | -0.555 |
VRTX | 448.89 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 746.20 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 597.08 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.44 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 108.14 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-01-04 | Aggiornamento | Societe Generale | Hold → Buy |
2022-12-16 | Downgrade | Goldman | Neutral → Sell |
2022-05-10 | Downgrade | Goldman | Buy → Neutral |
2021-09-14 | Aggiornamento | Societe Generale | Hold → Buy |
2021-01-22 | Downgrade | Societe Generale | Hold → Sell |
2020-11-02 | Aggiornamento | Societe Generale | Sell → Hold |
2020-08-06 | Downgrade | Societe Generale | Buy → Sell |
2020-08-05 | Reiterato | H.C. Wainwright | Buy |
2020-03-17 | Downgrade | Stifel | Buy → Hold |
2020-01-09 | Aggiornamento | Stifel | Hold → Buy |
2019-12-16 | Iniziato | Citigroup | Buy |
2019-09-05 | Ripresa | Morgan Stanley | Equal-Weight |
2019-06-17 | Iniziato | Goldman | Buy |
2018-12-20 | Downgrade | Barclays | Overweight → Equal Weight |
2018-12-20 | Downgrade | BofA/Merrill | Buy → Underperform |
2018-12-20 | Downgrade | Jefferies | Buy → Hold |
2018-12-20 | Downgrade | Stifel | Buy → Hold |
2017-10-31 | Aggiornamento | Societe Generale | Sell → Hold |
2017-10-24 | Downgrade | Societe Generale | Buy → Sell |
2017-10-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2017-06-23 | Iniziato | Deutsche Bank | Buy |
2017-03-16 | Aggiornamento | Societe Generale | Hold → Buy |
2016-09-26 | Iniziato | JMP Securities | Mkt Outperform |
2015-12-03 | Iniziato | Barclays | Overweight |
2015-10-23 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Dbv Technologies Adr Borsa (DBVT) Ultime notizie
DBV Technologies (STU:DBV0) Shares Outstanding (EOP) : 96.20 Mil (As of Sep. 2024) - GuruFocus.com
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower - MSN
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading - MSN
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week - MSN
European Equities Traded in the US as American Depositary Rise Thursday - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - MSN
StockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World
DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
DBV Technologies Stock to Reverse Split on Friday, November 29th (NASDAQ:DBVT) - Defense World
DBV Technologies Stock Set to Reverse Split on Friday, November 29th (NASDAQ:DBVT) - MarketBeat
DBV Technologies Announces Plan to Implement ADS Ratio Change - The Manila Times
DBV Technologies Plans 1:5 ADS Ratio Change to Meet Nasdaq Requirements | DBVT Stock News - StockTitan
DBV Technologies’ stock slides as financial woes worsens - Pharmaceutical Technology
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - MSN
DBV Technologies Reports Third Quarter 2024 Financial Results - GlobeNewswire
DBV Technologies (NASDAQ:DBVT) Stock Price Passes Above 50 Day Moving AverageTime to Sell? - MarketBeat
DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - Defense World
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - MSN
DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World
DBV Technologies (NASDAQ:DBVT) Receives New Coverage from Analysts at StockNews.com - MarketBeat
European Equities Traded in the US as American Depositary Receipts Gain Wednesday - MSN
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - MSN
HC Wainwright Forecasts Higher Earnings for DBV Technologies - Defense World
European Equities Traded in the US as American Depositary Receipts Rise Slightly Higher in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN
Data-Based Insights About DBV Technologies ADR (DBVT) - Stocks Register
HC Wainwright Has Positive Forecast for DBVT FY2024 Earnings - MarketBeat
GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register
Paramount Global (NASDAQ: PARA): Blank Check On Growth? - Stocks Register
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading - MSN
H.C. Wainwright raises DBV Technologies shares price target, keeps Buy rating - Investing.com India
DBV Technologies (NASDAQ:DBVT) PT Raised to $7.00 - MarketBeat
The United States Allergy Immunotherapy Market Size & Outlook, 2027 - Grand View Research
DBV Technologies ADR (NASDAQ: DBVT) Is The Number One Stock Currently Moving. - Stocks Register
Atlantic Union Bankshares Corp Still Hasn’t Convinced Analysts? - Stocks Register
H.C. Wainwright & Co. Raises Price Target on Biotech Following Positive Regulatory Updates - Streetwise Reports
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe - GlobeNewswire
DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress - The Manila Times
DBV Technologies S.A. - Via Ritzau
Peanut Protein Patch Market Report to 2032 -DBV Technologies, Segment - IndiaPolitics.com
Dbv Technologies Adr Azioni (DBVT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Dbv Technologies Adr Azioni (DBVT) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Mohideen Pharis | Chief Medical Officer |
May 24 '24 |
Sale |
1.36 |
660 |
898 |
81,152 |
Mohideen Pharis | Chief Medical Officer |
May 22 '24 |
Sale |
1.38 |
382 |
527 |
81,812 |
Tasse Daniel | CHIEF EXECUTIVE OFFICER |
Mar 08 '24 |
Buy |
0.83 |
17,094 |
14,188 |
17,094 |
Ndu Adora | Director |
Feb 06 '24 |
Buy |
0.89 |
1,825 |
1,624 |
1,825 |
Mohideen Pharis | Chief Medical Officer |
Nov 22 '23 |
Sale |
1.74 |
2,245 |
3,906 |
82,194 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):